Dynamic Augmentation of Left Ventricle and Mitral Valve Function With an Implantable Soft Robotic Device

•LVSD is associated with reduced LV systolic function and geometrical changes.•MVR results from LVSD.•Current management strategies address LVSD and secondary MVR separately, even in advanced stages of LVSD.•We describe an implantable soft robotic device that would provide a new paradigm in supporting patients with coexistence of LVSD and concomitant MVR by dynamically augmenting native LV contraction and supporting the mitral valve apparatus to eliminate the associated MVR.